|
INTI Inhibitor Therapeutics Inc 1042418 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-686,425.00 |
| Balance Sheet |
|
Current Assets
|
$1,375,953.00 |
|
Assets
|
$1,433,363.00 |
|
Current Liabilities
|
$382,320.00 |
|
Liabilities
|
$3,411,700.00 |
|
Equity
|
$-1,978,337.00 |
|
Shares Out
|
172573545.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-1,084,515.00 |
| Market Analysis |
Market Cap
|
$13,805,883.60 |
|
Price
|
$0.08 |
|
PB
|
0.77 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:44 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:44 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INTI documents filed with the SEC.
INTI Filings
Clear
